exact
caus
preterm
infant
increas
suscept
rvi
remain
unknown
current
literatur
point
combin
inflammatori
condit
utero
birth
immatur
dysfunct
immun
system
genet
epigenet
factor
rvi
first
year
life
associ
recurr
respiratori
morbid
includ
asthma
wheez
though
remain
determin
respiratori
virus
caus
morbid
exacerb
underli
genet
predisposit
children
rsv
particular
strongli
associ
develop
respiratori
sequela
though
rhinoviru
human
metapneumoviru
implic
well
patient
rsv
infect
normal
immun
respons
follow
threestep
pattern
innat
epitheli
respons
nasal
mucosa
antibodi
respons
specif
igg
upper
airway
protect
infect
lower
respiratori
tract
cell
respons
respons
viral
clearanc
preterm
neonat
defici
immun
respons
pathogen
overli
aggress
unregul
respons
other
along
preterm
infant
congenit
heart
diseas
syndrom
congenit
neuromuscular
diseas
cystic
fibrosi
congenit
immunolog
defici
particularli
high
risk
sever
rvi
particularli
rsv
infant
congenit
heart
diseas
rsv
infect
lower
respiratori
tract
may
caus
varieti
potenti
fatal
complic
includ
sinoatri
block
tachyarrhythmia
atrioventricular
block
vari
entiti
pericard
myocard
import
palivizumab
prophylaxi
popul
well
document
see
chapter
immun
nurseri
similarli
children
syndrom
consid
high
risk
sever
rsv
infect
due
underli
heart
diseas
frequent
accompani
condit
infant
congenit
neuromuscular
diseas
also
high
risk
rvi
due
reduc
vital
capac
lung
weak
cough
dysphagia
inhibit
clearanc
respiratori
excret
compromis
abil
compli
physiotherapeut
intervent
recurr
aspir
due
gastroesophag
reflux
diseas
vomit
due
cough
preterm
infant
cystic
fibrosi
also
risk
acceler
declin
respiratori
function
cours
live
due
rsv
infect
patient
extrem
suscept
recurr
wheez
bacteri
superinfect
commonli
pseudomona
aeruginosa
secondari
rsv
infect
rsv
known
facilit
pseudomona
aeruginosa
infect
prolifer
popul
final
patient
sever
immunocompromiseeith
due
transplant
hiv
digeorg
syndrom
sever
combin
immunodefici
etchav
defici
cell
lymphocyt
respons
inhibit
viral
clearanc
caus
greater
virul
persist
higher
viral
load
addit
rsv
human
metapneumoviru
pose
set
challeng
nicu
clinician
contrast
rsv
hospit
peak
around
age
month
metapneumoviru
hospit
peak
age
month
human
metapneumoviru
second
commonli
detect
viral
pathogen
rsv
may
greater
predilect
preterm
infant
compar
children
infect
rsv
anderson
et
al
found
infant
human
metapneumoviru
infect
prematur
mean
vs
week
gestat
like
bronchopulmonari
dysplasia
vs
similar
rsv
increas
risk
human
metapneumoviru
patient
bronchopulmonari
dysplasia
persist
second
year
life
immunocompromis
patient
adenoviru
particularli
danger
dissemin
diseas
local
sever
infect
respiratori
tract
infect
adenoviru
infect
neonat
rare
mortal
exce
adenoviru
pneumonia
dissemin
adenoviru
diseas
dissemin
diseas
may
present
pneumonia
hepat
hypothermia
apnea
nasal
congest
tachypnea
cyanosi
poor
feed
emesi
hypotens
neutropenia
hematuria
hypotonia
gener
clinic
find
rvi
nurseri
set
signific
overlap
pathogen
tabl
sign
includ
upper
respiratori
rhinorrhea
cough
stridor
lower
respiratori
tachypnea
desatur
crackl
wheez
retract
find
preterm
infant
respiratori
deterior
apnea
common
nonspecif
find
eg
feed
intoler
temperatur
instabl
also
seen
new
evolv
radiograph
chang
sensit
lower
respiratori
tract
involv
preterm
infant
difficult
differenti
viral
bacteri
pneumonia
absenc
test
mention
extrapulmonari
find
hepat
myocard
set
rvi
particularli
concern
adenovir
infect
sever
rsv
diseas
diagnosi
rvi
nicu
occur
two
distinct
phase
clinic
diagnosi
etiolog
diagnosi
clinic
diagnosi
deriv
physic
examin
medic
histori
infant
rvi
present
nonspecif
find
temperatur
instabl
apnea
respiratori
deterior
may
difficult
differenti
infant
lateonset
sepsi
see
chapter
lateonset
sepsi
viral
test
differenti
rvi
bacteri
infect
rvi
suspect
determin
etiolog
still
use
may
assist
antimicrobi
stewardship
effort
identifi
ongo
horizont
transmiss
within
unit
identifi
infant
could
benefit
antivir
therapi
ie
influenza
serolog
test
viral
cultur
rare
use
longer
diagnos
rvi
instead
nasopharynx
rare
bronchoscopi
fluid
directli
test
viral
materi
rapid
antigen
detect
test
collect
nasal
lavag
swab
offer
result
min
sensit
though
fals
neg
report
children
age
less
month
polymeras
chain
reaction
gold
standard
test
respiratori
virus
offer
sensit
specif
filmarray
respiratori
panel
salt
lake
citi
utah
usa
current
allow
test
respiratori
virus
bacteria
singl
sampl
roger
et
al
found
implement
rapid
respiratori
panel
test
significantli
reduc
durat
antibiot
use
length
inpati
stay
patient
time
isol
find
support
use
pcr
test
indic
avail
except
oseltamivir
influenza
infect
specif
antivir
therapi
avail
treatment
rvi
infant
treatment
instead
limit
support
care
supplement
oxygen
intraven
hydrat
nebul
hyperton
salin
also
shown
safe
effect
respiratori
support
insuffici
evid
efficaci
bronchodil
steroid
antibiot
respiratori
physic
therapi
treatment
bronchiol
intern
guidelin
bronchiol
treatment
remain
limit
supplement
oxygen
intraven
fluid
influenza
dose
recommend
avail
term
preterm
infant
howev
safeti
data
limit
infant
younger
month
treatment
reserv
highrisk
case
infant
acut
respiratori
decompens
extrem
prematur
prevent
best
medicin
rvi
preterm
infant
absenc
antivir
therapi
vaccin
rvi
environment
prophylaxi
effect
mean
prevent
complianc
hand
hygien
protocol
decontamin
object
surfac
nicu
shown
effect
reduc
preterm
infant
exposur
rvi
especi
devast
infect
rsv
addit
prevent
measur
includ
activ
surveil
test
cohort
infect
infant
away
test
neg
use
pathogenspecif
precaut
see
chapter
principl
infect
prevent
nurseri
limit
patient
contact
visitor
elig
patient
palivizumab
safe
effect
mean
pharmacolog
prophylaxi
rsv
american
academi
pediatr
committe
infecti
diseas
bronchiol
guidelin
committe
issu
new
recommend
infant
elig
receiv
palivizumab
prophylaxi
see
chapter
immun
nurseri
final
recent
research
focus
effect
restrict
sibl
visit
patient
nicu
prevent
rvi
peluso
et
al
demonstr
signific
reduct
rsv
infect
implement
restrict
visitor
age
year
similarli
caserta
et
al
found
visitor
restrict
children
less
year
combin
hand
hygien
protocol
associ
significantli
lower
rate
infect
term
infant
live
commun
preterm
infant
discharg
hospit
find
highlight
need
addit
research
develop
improv
protocol
prevent
rvi
nicu
